naltrexone-bupropion
Selected indexed studies
- Naltrexone-Bupropion. (, 2012) [PMID:32687293]
- Bupropion and Naltrexone in Methamphetamine Use Disorder. (N Engl J Med, 2021) [PMID:33497547]
- Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial. (Obesity (Silver Spring), 2023) [PMID:37751990]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Naltrexone/bupropion for obesity. (2017) pubmed
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). (2013) pubmed
- Naltrexone/bupropion: Contrave(R); naltrexone SR/bupropion SR. (2010) pubmed
- Obesity Management in Adults: A Review. (2023) pubmed
- Bupropion and Naltrexone in Methamphetamine Use Disorder. (2021) pubmed
- Medications for Obesity: A Review. (2024) pubmed
- Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial. (2023) pubmed
- Naltrexone-Bupropion. (2012) pubmed
- Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial. (2022) pubmed
- Cardiovascular safety of naltrexone and bupropion therapy: Systematic review and meta-analyses. (2021) pubmed